A controlled SIWR model was considered which was an extension of the simple SIR model by adjoining a compartment W that tracks the pathogen concentration in the water. New infections arise both through exposure to contaminated water as well as by the classical SIR person-person transmission pathway. The controls represent an immune boosting and pathogen suppressing drugs. The objective function is based on a combination of minimizing the number of infected individuals and the cost of the drugs dose. The optimal control is obtained by solving the optimality system which was composed of four nonlinear ODEs with initial conditions and four nonlinear adjoint ODEs with transversality conditions. The results were analysed and interpreted numerically using MATLAB.
Introduction
Most of the major problems that humanity face in the twenty-first century are related to water quantity and/or quality issues. These problems are going to be more aggravated in future by climate change, resulting in higher water temperatures, melting of glaciers, and an intensification of the water cycle 1 , with potentially more floods and droughts 2 . With respect to human health, the most direct and most severe impact is the lack of improved sanitation, and related to it is the lack of safe drinking water, which currently affects more than one-third of the global population. Additional threats include, for example, exposure to pathogens or to chemical toxicants via the food chain, for instance, the result of irrigating plants with contaminated water and of bioaccumulation of toxic chemicals by aquatic organisms, including seafood and fish or during recreation like swimming in polluted surface water.
International Journal of Mathematics and Mathematical Sciences 3 illustrated using a case study that focuses on diseases associated with water and sanitation management practices in developing countries where the disease burden is the most severe. Schwarzenbach et al. 17 discussed the main groups of aquatic contaminants and their effects on human health and approached to mitigate pollution of freshwater resources. Rahman et al. 18 determined the antibiotic potential of the extracts of the leaf and stem of Argemone mexicana as a natural antimicrobial agent against the waterborne bacteria. Joshi 19 described the interaction of HIV and T cells in the immune system, and he explored the optimal controls representing drug treatment strategies. Zhang et al. 20 studied the HIV virus spread model with control variables to maximize the number of healthy cells and to minimize the cost of chemotherapy. Castilho 21 studied the optimal strategies for a limited-cost educational campaign during the outbreak of an epidemic. Joshi et al. 22 have illustrated the idea of optimal control in two types of disease models by treating two examples. In the first example, they considered an epidemic model with two different incidence forms. In the second example, they illustrated a drug treatment strategy in an immunology model. Brocka and Xepapadeas 23 have illustrated the analytical methods for recursive infinite horizon inter-temporal optimization problems with three stylized applications. The first application is the optimal management of spatially connected human-dominated ecosystems. The second and third applications are harvesting of spatially interconnected renewable resources. Iacoviello and Liuzzi 24 studied the optimal control problem for SIR-epidemic model in which multiple controls, both for the susceptible and infected, are considered. Yan and Zou 25 discussed the application of the optimal and suboptimal Internet worm control using Pontryagin's maximum principle. In this model, the control variable represents the rate of treatment to remove infectious hosts from circulation by filtering or disconnection from the Internet. Blayneh et al. 26 have studied the dynamics of a vector-transmitted disease using coupled deterministic models with two controls.
Rowthorn et al. 27 used a combination of optimal control methods and epidemiological theory for metapopulations to minimize the number of infected individuals during the course of an epidemic. They found an optimal path by an anti-MRAP strategy which satisfies Hamilton and transversality conditions. Bhattacharyya and Ghosh 28 studied the basic reproduction ratio, stability of the solutions under realistic biological parameters for the vertically transmitted diseases, and by the application of Pontryagin's maximum principle, they performed the optimal analysis of the control model considering the antiviral drug to the infective and vaccination to the susceptible as control parameters. Shirazian and Farahi 29 showed the implementation of mathematical models to formulate guidelines for clinical testing and monitoring of HIV/AIDS disease. Numerical results were obtained using mathematical softwares, LINGO and MATLAB. Prosper et al. 30 applied optimal control in the context of SAIR model with two controls, namely, social distancing and antiviral treatment, in minimizing the number of H1N1 infections in the seasonal and pandemic H1N1 influenza.
Rodrigues et al. 31 investigated the optimal vaccination strategy for the dengue epidemic considering both the costs of treatment of infected individuals and the costs of vaccination. The optimal control problem was solved using two methods: direct and indirect. The direct method uses the optimal functional and the state system and was solved by DOTcvpSB. It is a toolbox implemented in MATLAB, which uses numerical methods for solving continuous and mixed-integer dynamic optimization problems. The indirect method uses iterative method with a Runge-Kutta scheme and solved through ode45 of MATLAB. Tchuenche et al. 32 derived the optimality system and used the Runge-Kutta fourth-order scheme to numerically simulate the treatment and vaccination efforts for the dynamics of 33 investigated an effective strategy to control the computer virus by setting an optimal control problem in the SIRA model. The optimality system is numerically solved by applying MATLAB with a Runge-Kutta fourth-order scheme.
To the best of our knowledge, optimal control theory has not been implemented to study waterborne diseases. The objective of the work is to find the optimal control of water borne diseases. The optimal control strategies in the form of immune boosting and pathogen suppressing drugs were used.
Optimal Control of Waterborne Disease Model

Mathematical Formulation
Consider the standard SIR model under the assumption of constant population size, together with a compartment W that measures pathogen concentration in a water source 34 . Susceptible individuals become infected either by contact with infected individuals or through contact with contaminated water. Infected individuals can in turn contaminate the water compartment by shedding the pathogen into W. An infected individual thus generates secondary infections in two ways: through direct contact with susceptible individuals and by shedding the pathogen into the water compartment, which susceptible individuals subsequently come into contact with it. The corresponding model equations arė
2.1
Here, S represent the susceptible individual density, I represents the infected individual density, R represents the recovered/removed individual density, and W represents the pathogen concentration in water reservoir. Here, b W and b I are the transmission rate parameters for water-to-person and person-to-person contact, respectively. The birth and non-diseaserelated death rate is given by μ. The mean infectious period is given by 1/γ. The pathogen shedding rate from infected individuals into the water compartment is given by α, and ξ gives the decay rate of pathogen in the water.
Rescaling the system of the model 2. The objective functional is defined as
where A 1 and A 2 are positive weights that balance the size of the terms. Here the number of infected individuals and cost of the immune boosting and pathogen suppressing drugs are minimized. The optimal control pair u * 1 , u * 2 were obtained such that
where
is the admissible control set.
Existence of an Optimal Control
The existence of the optimal control pair for the state system 2.3 can be obtained by using a result by Fleming and Rishel 35 . 
Proof. To use an existence result, Theorem III. 4.1 from 35 , the following conditions should be satisfied:
1 the set of controls and corresponding state variables is nonempty;
2 the control set U is convex and closed; 
because the state variables are bounded. We conclude that there exists an optimal control pair.
Characterization of the Optimal Control Pair
In order to derive the necessary conditions for the optimal control pair, the Pontryagin's maximum principle 37 was used. The Hamiltonian is defined as follows: 
2.9
and p 1 T p 2 T p 3 T p 4 T 0, the transversality conditions. Furthermore,
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Proof. The form of the adjoint equations and transversality conditions are standard results from Pontryagin's maximum principle 37 . The adjoint system can be obtained as follows:
2.11
The optimality equations were given by:
2.12
Hence,
2.13
By using the bounds for the control u 1 , we get
2.14
In compact notation,
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By using the bounds for the control u 2 , we get
2.16
In compact notation, 
Numerical Results
In this section, the optimality system has been solved numerically, and the results have been presented. In this formulation, there were initial conditions for the state variables and terminal conditions for the adjoints. That is, the optimality system is a two-point boundaryvalue problem, with separated boundary conditions at times t 0 and t T . So the aim is to solve this problem for the value T 20. This value was chosen to represent the time in hours at which treatment is stopped. An efficient method to solve two-point BVPs numerically is collocation. A convenient collocation code is the solver BVP4c implemented under MATLAB, which can be used to solve nonlinear two-point BVPs. It is a powerful method to solve the two-point BVP resulting from the optimality conditions. The different variables in the objective functional 2.4 , namely, the infected persons and the drug dosage, have different scales. Hence, they are balanced by choosing weighting values. Only if the value of A 1 is higher than the value of A 2 , the graphs are obtained correctly, whereas if the value of A 1 is lower than the value of A 2 , then the graphs are not obtained. Figure 1 represents the controls u * 1 and u * 2 for the drug administration. The immune boosting drug is administered in full scale nearly up to 20 hours and then is tapered off. Similarly, the pathogen suppression drug is administered in full scale nearly up to 20 hours and then is tapered off.
The first figure represents the optimal path for the immune boosting control. The immediate rise of the curve from the negative part to the positive part is directly dependent upon the action of the immune response, which occurs shortly after treatment initiation in response to the high infection level. This implies that the optimal treatment actually happened. After that, the curve is constant in the positive level which denotes that the specific immune response is always maintained constant.
The second figure represents the optimal path for the pathogen suppressing drug. Here also the curve increases from the negative level to the constant positive level which denotes that the pathogen has suppressed fully and maintained that constant.
In Figure 2 , the first figure represents the number of susceptible individuals during our treatment period. The susceptible individuals have a sharp decrease, and then after one or two hours, they become constant steadily. This clearly indicates that no other susceptible individuals become infected after the administration of the drugs.
The second figure represents the number of infected individuals during our treatment period. In the beginning, a sharp increase in the number of infected individuals has been observed because the drug takes some time to react with the infected individuals as they are highly infected by the pathogens, and then after one hour, it starts to decrease steadily linearly with time since the infected persons acquired immunity. It is possible to see that the controls, which means that everyone is vaccinated, imply that eradication of the disease. The third figure represents the pathogen concentration during the treatment period. In the beginning, a steady increase in the curve has been observed which denotes an increase in the pathogen concentration as the pathogen adapts to the environment and grows efficiently in the absence of drugs. Then after few hours, it starts to decrease steadily since the pathogens have been suppressed by the drug. The fourth figure represents the number of recovered individuals during our treatment period. A steady increase in the number of recovered individuals linearly with time has been noticed since the individuals have been recovered completely. Figure 3 represents the cost of the optimal drug treatment. The curve increase to near their maximal level initially because in the high infection level, the dose of drugs will be large which in turn represents the cost of the drugs used. Then it drops off steadily which is because of the constant and steady eradication of the infection. Figure 4 represents the controls u * 1 and u * 2 for the drug administration. The immune boosting and pathogen suppressing drugs are administered in full scale nearly up to 100 hours and then are tapered off.
The graph shows that the immune boosting and pathogen suppressing drugs are fully functional and active at 20 hours which is the critical point, and continuous administration of the drug beyond 20 hours proves pointless which could increase the cost of the drug, antibiotic resistivity, and other side effects which is shown in the graph as noise.
In Figure 5 , the first figure represents the number of susceptible individuals during our treatment period. While the treatment is continued beyond 20 hours to 100 hours, the number of susceptible individuals increases which is due to the antibiotic resistance developed by the pathogen in the individuals.
The second figure represents the number of infected individuals during our treatment period. A sharp decrease and an increase in the number of infected individuals have been observed at the later stage of the therapy time due to the antibiotic resistance and the other pathological side effects caused by excess anti-pathogenic drugs. The third figure represents the pathogen concentration during the treatment period. In the beginning, a steady increase in the curve has been observed which denotes an increase in the pathogen concentration as the pathogen adapts to the environment and grows efficiently in the absence of drugs. Then after few hours, it starts to decrease steadily since the pathogens have been suppressed by the drug. But after continuous administration of the drug, the pathogen gains resistivity against the drug and starts to grow luxuriously. Hence, the 20 hours is the critical period of the therapy, and continuing beyond 20 hours is not desirable.
Similarly, the fourth figure represents the number of recovered individuals during our treatment period. A steady increase in the number of recovered individuals linearly with time has been noticed since the individuals have been recovered completely. However if the treatment period is continued beyond 20 hours, the number of the recovered individuals gets reduced due to the side effects of the prolonged drug intake. Similar result, are observed for cost of the drug administration also Figure 6 .
The graphs were plotted for nonzero birth rate too. It was inferred from Figures 7, 8 , and 9 that no changes were observed when compared to the zero birth rate graphs.
For non-zero birth rate μ 29; the average birth rate in India per minute . In the present study, it is shown that how both the vaccines resulted in minimizing the number of infected individuals and at the same time in a reduction of the budget related with the disease. One of the goals in this work is to develop a technique which could be used by the medical community to determine drug dosing tailored for individual patients. Determining such an optimal strategy would be of tremendous practical value, provided that reasonable estimates can be made for the parameter values for a given individual. To this end, a parameter-fitting exercise backed up by substantial experimental data would be very useful and could have a significant impact in improving drug therapy for a patient. It is hoped that the experiments will be performed to provide the data necessary for improved estimates on some parameters, allowing for a more precise determination of optimal treatment protocols for patients.
